Injection blow molding and extrusion blow molding are the two principal blow molding processes in Korean packaging — yet they serve different container markets, produce different neck precision, generate different levels of material waste and justify different capital investments. This guide compares both processes across 12 technical and commercial factors so Korean packaging engineers can choose the correct process for each production requirement without ambiguity.
Korea Ever-Power Engineering Desk · Ansan-si · July 2026
IBM vs EBM — At a Glance
±0.05 mm
IBM neck OD tolerance — vs ±0.15–0.25 mm in EBM
Zero Flash
IBM material utilisation — EBM generates 7–15% flash scrap
Up to 30
IBM cavities at 10 ml — EBM typically 1–4 cavities at small format
12
Technical and commercial factors compared in this guide
Injection blow molding and extrusion blow molding both produce hollow plastic containers by inflating softened resin against a mould cavity with compressed air. That is where the similarity ends. The fundamental difference between the two processes lies in how the preform — the intermediate shape that is subsequently inflated into a bottle — is created. In IBM, the preform is injection moulded around a core rod with precision tooling that defines the neck geometry exactly. In EBM, the preform is a hollow tube of extruded plastic (the parison) that is clamped by the blow mould and inflated, with the neck geometry formed by the mould’s parting line rather than by a dedicated precision tool.
This single difference — injection-moulded preform versus extruded parison — cascades into twelve measurable technical and commercial differences that determine which process is correct for a Korean packaging factory’s specific container requirements. The twelve differences are not subjective preferences; they are engineering realities that flow directly from the process physics. Understanding them removes the ambiguity from the IBM vs EBM decision for Korean pharmaceutical, household chemical, cosmetic and food packaging operations.
IBM and EBM are not competing processes in most applications — they serve different container markets. IBM dominates Korean pharmaceutical small-format containers and Korean precision-closure packaging. EBM dominates Korean large-format industrial containers, jerry cans and containers requiring integral handles. The process choice becomes genuinely ambiguous only in the mid-range: Korean household chemical containers at 250–1,000 ml, Korean food jars at 100–500 ml, and Korean cosmetic wide-mouth packaging — where both processes are technically capable but differ in quality output, operating cost and capital requirements in ways that Korean factory engineers need to understand to make a justified investment decision.
In IBM, the core rod passes through the neck zone during both the injection phase and the blow phase. The neck’s thread OD, bore diameter, sealing surface and thread profile are all defined at Station 1 by the injection mould insert — a precision-machined steel tool that maintains ±0.02 mm dimensional tolerance on the neck cavity. Because the neck is formed by injection and the core rod holds its geometry throughout the blow phase, the blow pressure at Station 2 never contacts the neck surfaces. The finished bottle’s neck is dimensionally identical to the injection mould cavity — ±0.05 mm OD tolerance across all cavities, on every cycle.
In EBM, the neck geometry is formed by the blow mould’s parting line — the seam where the two halves of the blow mould meet around the extruded parison. The parting line must close around the parison at the neck position, and the dimensional accuracy of the neck is limited by the precision of the parting line closure and the variation in parison thickness at the neck zone. EBM neck OD tolerance is typically ±0.15–0.25 mm — three to five times wider than IBM. For Korean pharmaceutical CRC closures that require ±0.06 mm neck OD tolerance for push-and-turn engagement, and for Korean pump-dispenser closures that require ±0.08 mm neck OD for crimp-ferrule seal integrity, EBM neck precision is insufficient without secondary neck finishing operations (reaming or trimming) that add cycle time, equipment cost and scrap risk.
In IBM, the preform contains exactly the amount of resin needed for the finished bottle. There is no excess material at any mould boundary — the injection mould fills precisely, and when the preform is inflated at Station 2, the polymer redistributes from preform to bottle with no material exceeding the blow mould cavity. Zero flash is a structural feature of the IBM process, not a quality achievement — it is physically impossible for IBM to generate flash because there is no excess parison material to be pinched.
In EBM, flash is unavoidable. The extruded parison must extend beyond the top and bottom of the blow mould to allow the mould to close around it and pinch the excess off. Flash forms at the neck pinch-off (above the thread finish) and at the base pinch-off (below the base panel), accounting for 7–15% of the shot weight depending on bottle geometry and parison programming. This flash is either discarded as scrap or returned to the extruder as regrind — both options carry costs. Scrap flash increases resin cost per bottle; regrind adds process steps, consumes energy, and introduces resin quality risks (molecular weight reduction, colour change, increased brittleness on the third and fourth regrind cycle) that affect the final bottle’s mechanical properties. For Korean pharmaceutical production specifically, flash from EBM trim operations generates plastic particles that represent a contamination risk in cleanroom production environments — a risk that IBM’s zero-flash process eliminates entirely.
IBM’s zero-flash production means that every gram of resin injected at Station 1 appears in the finished bottle at Station 3. Material utilisation is 100%. The cost of resin in an IBM production run is the cost of the finished bottles plus the cost of the injection system runner material (which in hot runner systems is retained in the hot runner manifold and never solidifies, eliminating runner scrap entirely). In Korean HDPE pharmaceutical production where resin cost is the largest variable cost component, 100% material utilisation is a significant operating advantage over EBM.
EBM material utilisation depends on the bottle geometry and the parison programming: simple cylindrical bottles with standard neck and base pinch-off produce flash that accounts for 7–10% of shot weight; complex geometries with large base panels or oval cross-sections can generate flash approaching 15%. At Korean HDPE prices of KRW 1,400–1,800/kg and a Korean EBM production run of 1 million 500 ml bottles (approximately 22 tonnes of HDPE at 22g per bottle), a 10% flash rate represents approximately 2.2 tonnes of HDPE flash — a material cost of KRW 3.1–4.0 million per million bottles. Annualised at a Korean household chemical factory producing 20 million 500 ml bottles per year, the EBM flash material cost alone is KRW 62–80 million — a recurring annual cost that IBM eliminates entirely.
In IBM, the wall thickness distribution of the finished bottle is defined by the preform geometry — itself defined by the injection mould cavity and core rod dimensions. The preform’s wall thickness at each axial position is fixed by the mould tooling, not by a dynamic process parameter. This means IBM wall thickness consistency is a tooling characteristic: once the mould is correctly designed and manufactured, the wall thickness distribution is repeatable cycle to cycle, cavity to cavity, and shift to shift without operator adjustment. IBM bottle wall thickness coefficient of variation (CV%) is typically 3–6% across all cavities in a multi-cavity mould. In EBM, wall thickness is controlled by parison programming — a dynamic process where the die gap of the extruder head varies continuously during parison extrusion to produce a parison that, when inflated against the blow mould, produces the target wall thickness at each point. Parison programming is a skilled adjustment process that requires trained EBM operators to maintain; wall thickness CV% in Korean EBM production is typically 8–15%, and higher during startup and after material lot changes. For Korean food-grade containers where wall thickness uniformity directly affects stack compression strength (required for Korean retail pallet display), and for Korean pharmaceutical containers where wall thickness affects chemical permeation rate calculations in Korean KFDA container qualification, IBM’s tooling-defined wall uniformity is a measurable quality advantage over EBM’s operator-dependent parison programming.
The container volume range and output rate differences between IBM and EBM reflect the two processes’ different architectures — IBM’s multi-cavity precision approach versus EBM’s high-volume large-format capability.
| Volume / Output Factor | IBM | EBM |
|---|---|---|
| Minimum practical volume | 1 ml — micro pharmaceutical | ~30–50 ml — parison stability limit |
| Maximum volume (standard) | 2,000 ml | 500 L+ (industrial drums) |
| Cavities at 10 ml | Up to 30 (ZQ135) | 1–4 (parison stability limits multi-cavity) |
| Output at 10 ml (bottles/hour) | Up to ~27,000 | ~3,000–6,000 |
| Cavities at 500 ml | 5–8 (IBM) | 2–4 (EBM) |
| Output at 500 ml (bottles/hour) | ~5,400–7,200 (6-8 cav) | ~3,200–4,800 (2-4 cav) |
IBM’s effective volume range is 1–2,000 ml, with the lower end constrained by the minimum practical injection shot weight for a stable preform and the upper end constrained by the blow mould size that can be accommodated on the turret platform. EBM’s lower volume limit is approximately 30–50 ml, because very small parisons are unstable during extrusion — they sag, thin unevenly, and produce unacceptable wall thickness variation when inflated. Below 50 ml, EBM cannot reliably produce consistent bottles; IBM is the only blow molding process for Korean pharmaceutical ampoules and mini-bottles at 1–30 ml. EBM’s upper volume range is practically unlimited — industrial EBM machines produce jerry cans, drums and automotive fuel tanks at 5–500 litres, which IBM cannot approach.
At small container formats (10–100 ml) IBM’s multi-cavity advantage is most pronounced. A 30-cavity IBM machine at 10 ml produces approximately 27,000 bottles per hour at a 4-second cycle — an output rate that an EBM machine with 4 cavities at a 6-second cycle produces approximately 2,400 bottles per hour. This 11-to-1 output ratio at the smallest formats means that a Korean pharmaceutical factory requiring 20 million 10 ml containers per year needs one ZQ135 IBM machine running two Korean shifts, versus approximately ten EBM machines at equivalent cavities running the same schedule. The IBM investment is higher per machine but dramatically lower per unit of annual capacity at small formats. At larger formats (500 ml+), IBM’s cavity count advantage narrows: IBM at 6 cavities and EBM at 4 cavities produce within 30–50% of each other’s output, making the economics comparison more dependent on the operating cost differences (flash, scrap, operator skill) than on raw output rate.
EBM’s parison clamping architecture allows the blow mould to include a handle cavity that is integral with the bottle body — the parison is clamped to include the handle loop and inflated to fill both the bottle body and the handle simultaneously. This produces a handle that is structurally continuous with the bottle wall, with no weld line or adhesive joint — the correct design for Korean household chemical containers above 2 litres (cleaning fluid, laundry detergent, bulk bleach) and Korean food containers (cooking oil, vinegar, soy sauce) at 2–5 litres where a handle is both functionally necessary and ergonomically expected by Korean consumers. IBM’s rotary turret architecture does not permit integral handles: the core rod passes through the container’s interior throughout the process, and a handle that bridges from one side of the container to the other would prevent core rod extraction at Station 3. Korean IBM containers above 1 litre typically use a post-production applied handle (a separately moulded PP grip clipped or heat-staked onto the IBM bottle after production) rather than an integral handle — a two-component approach that adds assembly cost and eliminates the structural continuity of the EBM integral handle. For Korean containers where an integral handle is the design requirement, EBM remains the correct process regardless of the other advantages IBM offers.
IBM containers have no base seam and no parting-line witness marks on the body walls. Because the IBM blow mould does not have a parting line that crosses the container body — the core rod provides the interior surface and the blow mould provides only the outer cavity surface — the IBM bottle’s exterior is defined entirely by the blow mould cavity surface. Surface quality of an IBM blow mould at the body can be polished to Ra ≤ 0.05 μm (mirror finish), producing a bottle body that is visually indistinguishable from a glass container when moulded in high-clarity PS or PCTG. EBM containers have a horizontal base seam at the pinch-off line, a vertical parting line on the body where the two mould halves meet, and in some cases a trim mark at the neck where the neck flash was removed. These seam lines are acceptable in utility packaging (household chemical, agricultural, industrial) but are a visual quality concern for Korean premium cosmetic jars and Korean pharmaceutical containers where label panels are designed to exactly cover the parting line and the base seam is visible from shelf-side. IBM’s seam-free exterior is a design quality advantage that supports Korean premium packaging positioning without surface finishing operations after moulding.
Korean pharmaceutical container production is governed by Korean KFDA (Ministry of Food and Drug Safety) pharmaceutical packaging regulations that specify dimensional tolerances for container neck finishes used with pharmaceutical closure systems. The Korean pharmaceutical closure standards — particularly for CRC (child-resistant closure) containers, crimp-top vials and pump-dispenser pharmaceutical bottles — require neck OD tolerances of ±0.06–0.08 mm for the closure to function as intended and pass Korean GMP qualification testing. IBM consistently meets these tolerances as a native process capability. EBM requires secondary neck finishing (reaming, trimming or post-mould neck calibration) to achieve these tolerances, adding equipment, cycle time and scrap risk to pharmaceutical-grade EBM production.
Additionally, Korean GMP pharmaceutical production environments classify particle generation as a contamination risk. IBM’s zero-flash production eliminates the flash trim station that EBM requires — a mechanical trimming operation that generates plastic particles from the flash removal. In Korean pharmaceutical ISO Class 8 cleanroom environments, operating an EBM flash trim station requires the trim station to be enclosed and exhausted to prevent particles from reaching the fill zone — an engineering requirement that IBM production avoids entirely. Korean pharmaceutical contract packaging facilities that have transitioned from EBM to IBM report elimination of particle-related batch rejection events as a primary quality benefit alongside the neck precision improvement.
IBM machines have a higher entry-level capital cost than equivalent-output EBM machines for the same format. A Korea Ever-Power injection blow molding machine at the ZQ60 level (14 cavities, 37 KW) represents a higher investment than a comparable Korean EBM machine at 2-cavity 500 ml production. This investment difference is most significant for startup Korean packaging factories with limited capital and long production run lengths at a single format — where EBM’s simpler architecture and lower upfront cost may justify the higher per-bottle operating cost of flash management and lower output rate. The IBM vs EBM investment calculus changes when Korean factories account for: (a) the trim station cost that EBM requires but is not included in the EBM machine price; (b) the annual flash material cost at Korean resin prices; (c) the additional operator required for the EBM trim station versus IBM’s single-operator production; and (d) the neck calibration equipment that Korean pharmaceutical EBM requires. When these downstream costs are included, the IBM vs EBM total cost of ownership comparison over a 5-year production plan typically favours IBM for Korean pharmaceutical applications and for Korean household chemical production above 2 million units per year.
| Cost Factor | IBM | EBM |
|---|---|---|
| Machine purchase price | Higher | Lower |
| Trim station required | No | Yes — KRW 15–40M additional |
| Annual flash material cost (500ml, 5M units) | Zero | KRW 15–25M/year |
| Operators per machine | 1 | 1 machine + 1 trim station = 2 |
| 5-year total cost of ownership (pharma) | Lower | Higher when all operating costs included |
Energy consumption per 1,000 finished bottles is the most relevant energy comparison metric for Korean packaging factories, because it accounts for the output rate difference between IBM and EBM — comparing total machine power consumption without normalising for output would incorrectly penalise the more productive machine. At 500 ml HDPE shampoo bottle production, a Korea Ever-Power EP-ZQ60 IBM machine running 3-cavity 500 ml at 37 KW total power produces approximately 2,700 bottles per hour — energy consumption of approximately 13.7 kWh per 1,000 bottles. A Korean EBM machine running 2-cavity 500 ml at 25 KW produces approximately 1,800 bottles per hour — energy consumption of approximately 13.9 kWh per 1,000 bottles. At this format, the energy difference is small. However, Korea Ever-Power’s ZQ80 and above machines add a dual hydraulic system that reduces actual operating power to 52–70% of rated total power during production — measured by Korean customers at 20–30% less electricity per 1,000 bottles versus competitor single-circuit IBM and EBM at the same format. For a Korean factory subject to Korean Ministry of Industry Energy Efficiency targets, this documented energy advantage directly improves the factory’s energy intensity reporting.
IBM’s zero-flash production eliminates a carbon cost that EBM carries on every production run: the embodied carbon in the flash material that is either scrapped or reprocessed. Scrapped HDPE flash at a typical Korean EBM facility represents wasted embodied carbon from resin production, transport and processing — approximately 1.9 kg CO₂e per kg of HDPE according to Korean LCA (Life Cycle Assessment) data for HDPE packaging. At 10% flash on a 500 ml Korean EBM bottle (22g bottle weight, 2.2g flash per bottle), approximately 4.2g CO₂e is wasted per bottle in flash material alone. At 20 million bottles per year, this is approximately 84 tonnes CO₂e per year — a Scope 3 emission that Korean packaging brands increasingly need to account for in Korean ESG reporting. IBM eliminates this flash carbon cost entirely, giving Korean IBM packaging producers a specific and quantifiable carbon advantage for Korean corporate ESG supply chain disclosure that EBM packaging cannot match.
The twelve differences above reduce to a simple decision framework for Korean packaging factories. The framework has three gates — answer each in order and stop at the first definitive answer.
Gate 1: Is an integral handle required?
If YES — use EBM. IBM cannot produce integral handles. No other factor overrides this. If NO — proceed to Gate 2.
Gate 2: Is the container volume above 2,000 ml?
If YES — use EBM. IBM’s practical ceiling is 2,000 ml; above this, EBM or ISBM large-format machines are required. If NO — proceed to Gate 3.
Gate 3: Does the container require Korean pharmaceutical GMP neck precision, zero flash, or high cavity count at small format?
If YES to any — use IBM. Korean pharmaceutical containers, Korean precision-closure packaging and Korean high-volume small-format production all resolve to IBM through Gate 3. If NO to all — compare IBM and EBM total cost of ownership for the specific format and annual volume, as both are technically viable and the decision is economic.
For Korean factories in the ambiguous zone — primarily Korean household chemical at 250–1,000 ml and Korean cosmetic wide-mouth jars at 50–250 ml — the economic comparison should include: IBM machine price versus EBM machine price plus trim station; annual flash material cost at the production volume and Korean HDPE price; operator headcount (IBM: one per machine; EBM: one machine + one trim station); neck calibration equipment for Korean pharmaceutical-grade EBM; and the 5-year mould amortisation for each process. Korea Ever-Power’s application engineers provide a formatted IBM vs EBM cost comparison template for Korean factories evaluating this decision at specific production volumes — available through the Korea Ever-Power enquiry process. For the full range of Korea Ever-Power’s IBM machine options from entry-level to flagship, the 4-Station ISBM Machine range covers PET-based applications where crystal clarity rather than HDPE/PP processing is the requirement.
Q1 — Can a Korean factory run both IBM and EBM on the same production floor?
Yes, and many Korean packaging factories do exactly this. IBM and EBM are not substitutes for each other; they are complementary processes that serve different container formats. A Korean contract packaging facility producing 10 ml pharmaceutical eye drops (IBM) and 5-litre HDPE cleaning fluid with integral handle (EBM) needs both machines because no single process can produce both containers correctly. The shared infrastructure requirements — compressed air supply (both processes use blow air), cooling water circuit, and Korean 380V 3-phase electrical supply — mean the two machines can coexist on a shared Korean factory floor with shared utility distribution, reducing the per-machine infrastructure cost for Korean factories that operate both. The staff training requirements differ: IBM operators manage injection parameters, barrel zone temperatures and blow parameters as integrated settings on a single machine; EBM operators manage extrusion, parison programming and trim station as three separate functions. Korean factories that produce both IBM and EBM typically designate separate operator training tracks for each process rather than cross-training all operators on both, as the process physics are sufficiently different that cross-training creates confusion rather than flexibility at the critical parameter-setting stages.
Q2 — What is the biggest practical disadvantage of IBM compared to EBM for a Korean factory?
The biggest practical disadvantage of IBM versus EBM for Korean factories is the mould set cost and format change economics at large container formats. An IBM mould set for 500 ml shampoo at 6 cavities — including the injection mould, core rods, blow mould and stripping fixtures — costs significantly more than an EBM blow mould for 500 ml at 4 cavities, because IBM tooling requires three matched mould components (injection mould, blow mould, stripping tool) versus EBM’s single blow mould. For Korean contract packaging factories that produce 20–30 different container formats in small volumes per format — each requiring a dedicated mould set — the IBM mould investment per format is a significant capital commitment. Korean EBM contract packagers with 30 SKUs can carry 30 EBM blow moulds at a reasonable tooling investment; Korean IBM contract packagers carrying 30 IBM mould sets face a proportionally higher tooling inventory cost. The IBM mould investment disadvantage narrows as production volume per format increases — at high annual volumes per format, the IBM operating cost advantages (zero flash, higher output, lower operator cost) create a total cost per bottle that is lower than EBM, recouping the higher mould investment within 1–3 years depending on annual volume. At low annual volume per format (below 500,000 units per format per year), EBM tooling economics typically prevail.
Q3 — Why is the EBM base seam present on all EBM bottles, and can it be eliminated?
The EBM base seam — the horizontal raised line at the bottom of an EBM container where the two blow mould halves pinch the parison closed — is an unavoidable feature of the EBM process. The extruded parison must extend below the base of the blow mould cavity so that the mould halves can close around it and pinch it closed to form the sealed base. The amount of parison extending below the cavity at pinch-off becomes the base flash — which is removed by the trim station — and the pinch line itself leaves a small raised seam mark at the container base. This base seam cannot be eliminated without changing the process fundamentally. The seam height can be minimised by very precise EBM mould closure alignment and sharp pinch-off edge machining (achievable to approximately 0.1 mm raised height at best), but the seam cannot be reduced to zero in EBM as the pinch-off is a structural requirement of the process. IBM bottles have no base seam because there is no pinch-off: the preform base is injection moulded closed at Station 1 and simply inflates to the blow mould base profile at Station 2 without any pinching action. The IBM gate witness mark at the interior base is typically less than 0.5 mm in diameter and is not visible from outside the container. For Korean cosmetic brands specifying premium packaging where the base is visible to Korean consumers (transparent containers displayed upside-down in Korean department store cosmetic fixtures), IBM’s base seam elimination is a specific visual quality requirement that EBM cannot satisfy.
Q4 — Is IBM or EBM better for Korean household chemical HDPE containers at 500 ml?
For Korean household chemical HDPE containers at 500 ml, IBM is better when annual production volume exceeds approximately 2 million units per format per year; EBM may be better below this threshold. The economic break-even point depends on the specific Korean factory’s cost structure, but the key factors are as follows. At 2 million 500 ml units per year: IBM at 6 cavities (ZQ80 platform) produces approximately 7,200 bottles per hour and runs approximately 278 hours per year at this volume — a very low machine utilisation that makes the IBM machine investment difficult to justify unless the machine runs multiple other formats in the remaining hours. EBM at 4 cavities produces approximately 4,800 bottles per hour and runs approximately 417 hours — similarly low utilisation but at lower machine capital. At 10 million 500 ml units per year: IBM runs approximately 1,389 hours per year (40% of Korean two-shift annual hours), with zero flash, no trim station and higher output quality — the IBM operating cost advantage compounds and the machine investment per unit of output is justifiable. At 20 million units per year: IBM is clearly the superior economic choice — a single ZQ80 at 6-cavity 500 ml can produce 20 million units in approximately 2,778 hours (approximately 79% of two-shift Korean annual hours), with no flash cost, no trim station operator, and no neck calibration requirement. A Korean household chemical factory at this volume using EBM would need approximately 4 machines plus 4 trim stations to match this output, at a higher combined capital and operating cost. The Korean household chemical production threshold where IBM replaces EBM on economic grounds is typically 3–5 million units per year per format — Korean national brand shampoo and household cleaner lines that have been identified as IBM migration candidates by Korean packaging engineers reviewing their operating cost structure against the IBM investment case.
Q5 — How long does it take for a Korean EBM factory to transition to IBM production?
A Korean packaging factory transitioning from EBM to IBM production for a specific container format typically completes the full transition in 6–10 months from IBM machine order to GMP-qualified production. The timeline breaks down as follows. Months 1–2: IBM machine order and mould design. The IBM mould set design is substantially more complex than the EBM blow mould it replaces — three components (injection mould, blow mould, stripping tool) must be designed as an integrated system, and mould flow simulation is required for the injection mould to verify gate balance across all cavities. Months 2–4: IBM machine manufacture and mould manufacture proceed in parallel. Korea Ever-Power’s standard ZQ60 machine manufacturing time is 60–75 days; injection mould manufacture is 45–55 days. Months 4–5: Machine installation and commissioning at the Korean factory. Korea Ever-Power engineers install and commission the machine in 3–5 days, and operator training covers the IBM process parameters, mould change procedure, and quality inspection protocol over an additional 3–4 days. Months 5–6: IBM production trial and first-article qualification. The IBM machine produces trial bottles for Korean GMP container qualification documentation — dimensional report, closure engagement test, chemical compatibility test (for Korean pharmaceutical transition), and filled stability test. Months 6–10: Korean GMP qualification review by the Korean pharmaceutical brand customer or Korean KFDA notification (for Korean pharmaceutical containers). The limiting factor for Korean pharmaceutical IBM transitions is not the machine or mould manufacture — it is the Korean GMP qualification review timeline, which is typically 3–6 months from first-article sample submission to commercial production approval for Korean pharmaceutical container changes.
Q6 — Can IBM process the same materials as EBM?
IBM and EBM share compatibility with the principal Korean commodity thermoplastics — HDPE, PP and LDPE are processable on both platforms. The key material compatibility differences are: IBM processes ABS, PS and PCTG as standard IBM materials; these are technically processable in EBM but rarely used because they are single-layer commodity materials where IBM’s precision cavity produces better surface quality and dimensional consistency than EBM’s parison clamping. EBM processes multi-layer co-extrusion materials that IBM cannot — a 6-layer EVOH barrier parison for Korean condiment packaging requiring oxygen barrier cannot be produced in an IBM process because the IBM injection mould cannot produce a multi-layer preform with barrier layers. EBM’s co-extrusion capability makes it the only viable process for Korean barrier packaging (Korean tomato sauce, Korean kimchi base, Korean ready-to-eat meal packaging) where the container must include an EVOH or nylon oxygen barrier layer. IBM’s material range is inherently single-layer; multi-layer IBM is possible but rare and requires specialised injection manifold tooling. For Korean single-layer commodity packaging in HDPE, PP and ABS — which represents the large majority of Korean IBM applications — IBM and EBM are both material-compatible, and the process choice is determined by the dimensional, output and economic factors described in the other eleven differences above.
IBM Machine Enquiry
Korea Ever-Power provides IBM vs EBM total cost of ownership analysis, cavity count planning and production line economics comparison for specific Korean container formats and annual production volumes.
Related Resources
IBM PHARMACEUTICAL TABLET BOTTLE · PP HDPE OTC RX · CRC INDUCTION SEAL · KOREA…
IBM HAIR CARE BOTTLE · PP PCTG SHAMPOO CONDITIONER · K-BEAUTY OEM · KOREA EVER-POWER…
IBM CYCLE TIME · ZQ MACHINE PARAMETERS · COOLING DWELL · PP HDPE PCTG ·…
IBM MOULD STEEL · H13 P20 S136 TOOLING · HARDNESS POLISHABILITY · SERVICE LIFE ·…
IBM NECK FINISH STANDARDS · GPI BPF PCO THREAD · CRC FITMENT · NECK OD…
IBM DISINFECTANT BOTTLE · PP HDPE ANTISEPTIC · HAND SANITISER · ETHANOL · KOREA EVER-POWER…